venBio Partners — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
BiotechCambridge, US
Praveen Tipirneni(Executive Officer, Director)
BoardMichelle Doig(Director)inAaron Royston(Director)Michael Gladstone(Director)inXiaodi Su(Director)
Co-investorsAtlas VentureBain Capital Life SciencesJanus Henderson InvestorsLAVOmega FundsvenBio Global Strategic+1 more
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)Ruben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)
Co-investorsvenBio Global Strategic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.